ArticleMolecular neurobiology2025
Prediction of Post-Stroke Cognitive Impairment Based on Iron Metabolism Parameters: Results From A Prospective Study.
Article in Molecular neurobiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Blood-Based Biomarkers for Post-Stroke Cognitive Impairment.Current issues in molecular biology · 2026Review
- Decoding ferroptosis in intracerebral hemorrhage: multidimensional monitoring and integrative perspectives beyond single biomarkers.Frontiers in neurologyReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Disruption of iron homeostasis is associated with the pathogenesis of neurological disorders. This study aims to elucidate the correlation between serum iron metabolism profiles and the occurrence of post-stroke cognitive impairment (PSCI). Acute ischemic stroke (AIS) patients (n = 500) were enrolled, and serum iron metabolism parameters were collected at baseline. Cognitive abilities, including global cognition, episodic memory, language proficiency, attention, and executive function, were successfully assessed in participants six months after the AIS event (n = 224, mean age = 62). Multivariate logistic regression analysis was employed to screen for iron metabolism indicators influencing PSCI. A general linear model was used to analyze the correlation between total iron-binding capacity (TIBC) and overall cognitive function as well as performance in various cognitive domains. Additionally, we constructed a nomogram model to predict PSCI risk and validated its performance. The results revealed that the TIBC levels were significantly lower in the PSCI group. Elevated TIBC levels may represent a potential protective factor against PSCI development (OR = 0.940, 95% CI = 0.894-0.989, p = 0.018). Furthermore, higher serum TIBC levels were associated with better overall cognitive function, episodic memory, and language proficiency. The nomogram model constructed using age, gender, education level, National Institutes of Health Stroke Scale (NIHSS) score, and TIBC variables demonstrated good predictive performance for PSCI risk (AUC = 0.761, 95%CI = 0.696-0.825). In conclusion, serum TIBC is a potential biomarker for PSCI and is closely associated with cognitive ability.
Indexed as
Identifiers
40514564What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.